Physical activity: An essential component of lifestyle modification in NAFLD

Nature Reviews Gastroenterology and Hepatology

Volumn 9, Issue 12, 2012, Pages 726-731

  Rodriguez, Benjamin ^a   Torres, Dawn M ^a   Harrison, Stephen A ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBIC EXERCISE; CLINICAL EFFECTIVENESS; DIET THERAPY; DISEASE ASSOCIATION; EXERCISE INTENSITY; FATTY LIVER; HUMAN; KINESIOTHERAPY; LIFESTYLE MODIFICATION; NONALCOHOLIC FATTY LIVER; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RESISTANCE TRAINING; REVIEW; THERAPY EFFECT; TREATMENT OUTCOME;

DIET; FATTY LIVER; HUMANS; LIFE STYLE; MOTOR ACTIVITY; PATIENT COMPLIANCE; TREATMENT OUTCOME;

EID: 84870591332     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2012.200     Document Type: Review

References (25)

1. Chalasani, N. et al. The diagnosis and management of non-Alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005-2023 (2012).
2. Torres, D. M., Williams, C. D. & Harrison, S. A. Features, diagnosis, and treatment of nonalcholic fatty liver disease. Clin. Gastroenterol. Hepatol. 10, 837-858 (2012).
3. Bell, B. P. et al. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the Unites States: Results from population-based surveillance. Am. J. Gastroenterol. 103, 2727-2736 (2008).
4. Williams, C. D. et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-Aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology 140, 124-131 (2011).
5. Hallsworth, K. et al. Resistance exercise reduces liver fat and its mediators in non-Alcoholic fatty liver disease independent of weight loss. Gut 60, 1278-1283 (2011).
6. Palmer, M. & Schaffner, F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 99, 1408-1413 (1990). (Pubitemid 20381878)
7. Zelber-Sagi, S. et al. A double-blind randomized placebo controlled trial of orlistat for treatment of nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 4, 639-644 (2006).
8. Harrison, S. A., Fecht, W., Brunt, E. M. & Neuschwander-Tetri, B. A. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized prospective trial. Hepatology 49, 80-86 (2009).
9. Kirk, E. et al. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 136, 1552-1560 (2009).
10. Sreenivasa Baba, C. et al. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J. Gastroenterol. Hepatol. 21 (1 Pt 1), 191-198 (2006).
11. Lazo, M. et al. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care 33, 2156-2163 (2010).
12. Promrat, K. et al. Randomized control trial testing the effect of weight loss on nonalcoholic steatohepatitis. Hepatology 51, 121-129 (2010).
13. Kistler, K. D. et al. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am. J. Gastroenterol. 106, 460-468 (2011).
14. Zelber-Sagi, S. et al. Role of leisure-Time activity in nonalcoholic fatty liver disease: A population-based study. Hepatology 48, 1791-1798 (2009).
15. Hattar, L., Wilson, T. A., Tabotabo, L. A. & Abrams, S. H. Physical activity and nutrition attitudes in obese Hispanic children with non-Alcoholic steatohepatitis. World J. Gastroenterol. 17, 4396-4403 (2011).
16. Fealy, C. E. et al. Short-Term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease. J. Appl. Physiol. 113, 1-6 (2012).
17. Keating, S. E., Hackett, D. A., George, J. & Johnson, N. A. Exercise and non-Alcoholic fatty liver disease: A systematic review and meta-Analysis. J. Hepatol. 57, 157-166 (2012).
18. Van der Ploeg, H. P., Chey, T., Korda, R. J., Banks, E. & Bauman, A. Sitting time and all-cause mortality in 222,497 Australian adults. Arch. Intern. Med. 172, 494-500 (2012).
19. Dunstan, D. W. et al. Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care 35, 976-983 (2012).
20. Sullivan, S., Kirk, E. P., Mittendorfer, B., Patterson, B. W. & Klein, S. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 55, 1738-1745 (2012).
21. Johnson, N. A. et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50, 1105-1112 (2009).
22. Kantartzis, K. et al. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-Alcoholic fatty liver disease. Gut 58, 1281-1288 (2009).
23. Kawaguchi, T. et al. Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL 6 levels in patients with NAFLD: A pilot study. J. Gastroenterol. 46, 746-757 (2011).
24. Strasser, B., Siebert, U. & Schobersberger, W. Resistance training in the treatment of metabolic syndrome: A systematic review and meta-Analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism. Sports Med. 40, 397-415 (2010).
25. Strasser, B., Arvandi, M. & Siebert, U. Resistance training, visceral obesity and inflammatory response: A review of the evidence. Obes. Rev. 13, 578-591 (2012).